The slip
PARKINSON RECEIPTno. 7341
23 Oct 2026, 08:04 UTCdopamine neurons, braak
predictionMEF2A in dopamine neurons tracks Braak Lewy-body stage
registered700883825f9ead88
discovery-0.16 p=0.685 n=9
replication+0.35 p=0.354 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.16, p 0.685)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT9321df09f20653702014b1a4…
follows f8689b72b68e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7341: MEF2A in dopamine neurons, braak
- power
- full sample +0.11 (p 0.658, n 18), 95% CI -0.37 to +0.55. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.11 (p 0.664, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.09 (p 0.715, n 18). could be the mix.
- skeptic
- leave-one-out range +0.02 to +0.29, sign flips 0; without severely affected donors +0.11 (p 0.658, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MEF2A in dopamine neurons.
case closed: nothing better to follow up.